1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HCV GENOTYPE 1: WEEK 28 INTERIM ANALYSIS

Journal of Hepatology ◽

10.1016/s0168-8278(09)61061-8 ◽

2009 ◽

Vol 50 ◽

pp. S385-S386 ◽

Cited By ~ 5

Author(s):

M. Shiffman ◽

A. Ahmed ◽

I. Jacobson ◽

R. Pruitt ◽

E. Keeffe

Keyword(s):

Interim Analysis ◽

Controlled Study ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR

Journal of Hepatology ◽

10.1016/s0168-8278(09)61051-5 ◽

2009 ◽

Vol 50 ◽

pp. S381 ◽

Cited By ~ 8

Author(s):

B. Bacon ◽

M. Shiffman ◽

J. Lim ◽

A. Berman ◽

V. Rustgi ◽

...

Keyword(s):

Interim Analysis ◽

Controlled Study ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Hcv Genotype ◽

Peginterferon And Ribavirin ◽

Hcv Genotype 1

Download Full-text

1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HEPATITIS C GENOTYPE 1: FINAL REPORT

Journal of Hepatology ◽

10.1016/s0168-8278(10)61189-0 ◽

2010 ◽

Vol 52 ◽

pp. S461 ◽

Cited By ~ 3

Author(s):

M.L. Shiffman ◽

A. Ahmed ◽

I.M. Jacobson ◽

R.E. Pruitt ◽

E.B. Keeffe

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Study ◽

Final Report ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Peginterferon Alfa

Download Full-text

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

Hepatology ◽

10.1002/hep.20212 ◽

2004 ◽

Vol 39 (6) ◽

pp. 1702-1708 ◽

Cited By ~ 209

Author(s):

Lennox J. Jeffers ◽

William Cassidy ◽

Charles D. Howell ◽

Sylvia Hu ◽

K. Rajender Reddy

Keyword(s):

Black American ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(15)70050-2 ◽

2015 ◽

Vol 15 (4) ◽

pp. 397-404 ◽

Cited By ~ 212

Author(s):

Marc Bourlière ◽

Jean-Pierre Bronowicki ◽

Victor de Ledinghen ◽

Christophe Hézode ◽

Fabien Zoulim ◽

...

Keyword(s):

Protease Inhibitor ◽

Inhibitor Therapy ◽

Protease Inhibitor Therapy ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Hcv Genotype ◽

Phase 2 Trial ◽

Hcv Genotype 1

Download Full-text

Sa1053 Age-Dependent Rise in Early Hemoglobin (HB) Decline Contributes to a Higher Frequency of Anemia in Elder Patients Treated With Peginterferon Alfa-2B (Peg2b)/Ribavirin (RBV) for Chronic HCV Genotype 1 (G1) Infection

Gastroenterology ◽

10.1016/s0016-5085(12)63706-8 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-956

Author(s):

Gerlinde Teuber ◽

Stefan Mauss ◽

Dietrich Hüppe ◽

Elmar Zehnter ◽

Michael P. Manns ◽

...

Keyword(s):

Genotype 1 ◽

Hcv Genotype ◽

Elder Patients ◽

Age Dependent ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(13)60914-9 ◽

2013 ◽

Vol 58 ◽

pp. S376

Author(s):

G. Teuber ◽

S. Mauss ◽

D. Hüppe ◽

E. Zehnter ◽

M.P. Manns ◽

...

Keyword(s):

Sustained Virologic Response ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

Age-dependent rise in early Hemoglobin (Hb) decline contributes to a higher frequency of anemia in elder patients treated with peginterferon alfa-2b (Peg2b)/Ribavirin (RBV) for chronic HCV Genotype 1 (G1) infection

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1323994 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

G Teuber ◽

S Mauss ◽

D Hueppe ◽

E Zehnter ◽

MP Manns ◽

...

Keyword(s):

Genotype 1 ◽

Hcv Genotype ◽

Elder Patients ◽

Age Dependent ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naïve Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-00487 ◽

2013 ◽

Vol 108 ◽

pp. S145 ◽

Cited By ~ 2

Author(s):

Christophe Moreno ◽

Peter Ferenci ◽

Tarik Asselah ◽

Graham Foster ◽

Stefan Zeuzem ◽

...

Keyword(s):

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Pegylated Interferon Alfa ◽

Hcv Genotype 1 ◽

Chronic Hcv

Download Full-text

Sa1052 Thyroid Dysfunction Triggered by Peginterferon Alfa-2B / Ribavirin Treatment of Chronic HCV Genotype 1 Infection Favors Sustained Virologic Response (SVR) by Reducing

Gastroenterology ◽

10.1016/s0016-5085(12)63705-6 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-956

Author(s):

Stefan Mauss ◽

Dietrich Hueppe ◽

Elmar Zehnter ◽

Michael P. Manns ◽

Gerlinde Teuber ◽

...

Keyword(s):

Sustained Virologic Response ◽

Thyroid Dysfunction ◽

Virologic Response ◽

Genotype 1 ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hcv ◽

Peginterferon Alfa

Download Full-text

2001 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 NAIVE PATIENTS: WEEK 12 SUSTAINED VIROLOGIC RESPONSE RATE

Journal of Hepatology ◽

10.1016/s0168-8278(10)61192-0 ◽

2010 ◽

Vol 52 ◽

pp. S463 ◽

Cited By ~ 5

Author(s):

B.R. Bacon ◽

M.L. Shiffman ◽

J.K. Lim ◽

A. Berman ◽

V.K. Rustgi ◽

...

Keyword(s):

Response Rate ◽

Virologic Response ◽

Sustained Virologic Response Rate ◽

Controlled Study ◽

Phase 2 ◽

Genotype 1 ◽

Double Blind ◽

Peginterferon And Ribavirin ◽

Hcv Genotype 1 ◽

Virologic Response Rate

Download Full-text